Avertid

Avertid is intended to treat symptoms of vestibular vertigo, Meniere’s disease and syndrome.

Avertid restores the vestibular blood flow: improves the microcirculation and capillary permeability, increases the basilar artery blood flow. Avertid also increases the content of serotonin in synapses and normalizes the neural transmission between the vestibular apparatus and the brain.

Avertid is not sedating and does not induce drowsiness.